Penn Offers Total Lung Cancer Care
Lung
cancer is one of the most commonly diagnosed
cancers in men and women in the United States.
According to the American Cancer Society, approximately
213,000 new cases of lung cancer will be diagnosed
this year.
Today, however, there is more hope
than ever for patients who face lung cancer.
Diagnostic and treatment advances now offer
further help to patients who hope to conquer
this disease.
Symptoms of Lung Cancer
Symptoms are not always noticeable in the
early stages of lung cancer. When found in its
early stages, lung cancer is often detected by
tests performed for something else. Early symptoms
of lung cancer may include:
Comprehensive Treatment at the Penn Lung Center
No two patients' cases are the same
– each type of cancer requires a different
treatment. As a leader in the treatment of lung
cancer, the Penn
Lung Center at the University of Pennsylvania
Health System provides complete diagnostic evaluation
and advanced medical and surgical treatment for
lung disease and lung cancer.
Our pulmonologists,
chest surgeons, nurses, radiologists, lung pathologists,
medical and radiation oncologists, and researchers
have pioneered technological advances that are
rapidly being adopted as standard procedures
in their fields.
Penn offers the latest treatments and access to clinical trials for advanced lung cancer, and its physicians are specialists in the treatment of mesothelioma. This tradition of leadership in diagnosing and treating lung disease and lung cancer allows us to offer more patient care options than anyone else in the region. Our
team of lung specialists provide guidance, support and comfort during every phase of care.
Penn is the top rated program in the region for respiratory disorders, as ranked by U.S.News & World Report. For more information, please visit the Penn Lung Center web site.
The Abramson Cancer Center: A Research Leader
In addition to providing cutting edge treatment,
the Abramson
Cancer Center of the University of Pennsylvania
continues to be a leader in researching new ways
to prevent and treat lung cancer. Every day,
Penn scientists and physicians work to increase
their knowledge about lung cancer. In Penn's
lung cancer basic science laboratory, our team
learns about the development of lung cancer and
tests approaches that may ultimately lead to
improved patient care.
Our translational research
program brings laboratory findings to the clinical
setting, enabling us to test how well new treatments
compare with standard therapy. Because of these
efforts, research advances can more quickly benefit
our patients. Visit the Abramson Cancer Center
web site for a current list of lung
cancer clinical trials.
For more information about Penn's
Cancer Services or to meet with a Penn
cancer specialist, please call 800-789-PENN
(7366). You can also request
an appointment online.
|